Cell Chemical Biology

Papers
(The TQCC of Cell Chemical Biology is 16. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
Acute pharmacological degradation of ERK5 does not inhibit cellular immune response or proliferation176
Antisense-mediated senseful regulation of orchestrated metabolic response143
New sheriff in town: Cyclic peptide inhibitors of a DUB module134
Heterologous characterization of mechercharmycin A biosynthesis reveals alternative insights into post-translational modifications for RiPPs113
2′-OH as a universal handle for studying intracellular RNAs95
CBLs downregulation foretells T cell ubiquitination leading to autoimmunity93
Multiparatopic antibodies induce targeted downregulation of programmed death-ligand 191
Generation of an anticoagulant aptamer that targets factor V/Va and disrupts the FVa-membrane interaction in normal and COVID-19 patient samples91
Therapeutic potential of inhibiting the PI3Kγ complex for leukemia76
A versatile residue numbering scheme for Nav and Cav channels75
A genome-wide CRISPR-Cas9 screen identifies CENPJ as a host regulator of altered microtubule organization during Plasmodium liver infection68
Voices: Challenges and opportunities in regulating the immune system64
Development of potent and selective inhibitors targeting the papain-like protease of SARS-CoV-262
ITK degradation to block T cell receptor signaling and overcome therapeutic resistance in T cell lymphomas60
Identification of an inhibitory pocket in falcilysin provides a new avenue for malaria drug development59
Meet the Authors: Christopher R. Mansfield and Emily R. Derbyshire59
Inhibiting a dynamic viral protease by targeting a non-catalytic cysteine59
Dual-pharmacophore artezomibs hijack the Plasmodium ubiquitin-proteasome system to kill malaria parasites while overcoming drug resistance59
Advances in spatial proteomics: Mapping proteome architecture from protein complexes to subcellular localizations58
Control of topoisomerase II activity and chemotherapeutic inhibition by TCA cycle metabolites57
Next steps for targeted protein degradation56
FADS2-dependent fatty acid desaturation dictates cellular sensitivity to ferroptosis and permissiveness for hepatitis C virus replication52
Target deconvolution with matrix-augmented pooling strategy reveals cell-specific drug-protein interactions52
Targeted degradation of transcription factors by TRAFTACs: TRAnscription Factor TArgeting Chimeras52
A complex puzzle: Regulation of SLFN12 RNase activity by phosphorylation51
A fine-tuned azobenzene for enhanced photopharmacology in vivo51
Beyond antibiotic resistance: The whiB7 transcription factor coordinates an adaptive response to alanine starvation in mycobacteria50
Mechanisms by which microbiome-derived metabolites exert their impacts on neurodegeneration50
Peptide-mediated inhibition of the transcriptional regulator Elongin BC induces apoptosis in cancer cells50
A synthetic RNA-based biosensor for fructose-1,6-bisphosphate that reports glycolytic flux48
Catalytic spike antibodies: A new paradigm in neutralization47
Real-time non-invasive fluorescence imaging of gut commensal bacteria to detect dynamic changes in the microbiome of live mice46
Scribble sub-cellular localization modulates recruitment of YES1 to regulate YAP1 phosphorylation46
Meet the Authors: Harkamal S. Jhajj and Peter M. Tessier46
PALP: A rapid imaging technique for stratifying ferroptosis sensitivity in normal and tumor tissues in situ45
Anti-tumor effect of PD-L1-targeting antagonistic aptamer-ASO delivery system with dual inhibitory function in immunotherapy45
N6-methyladenosine modification in 18S rRNA promotes tumorigenesis and chemoresistance via HSF4b/HSP90B1/mutant p53 axis45
Peripherally active dextromethorphan derivatives lower blood glucose levels by targeting pancreatic islets44
The role of reversible and irreversible covalent chemistry in targeted protein degradation44
Visualizing Staphylococcus aureus pathogenic membrane modification within the host infection environment by multimodal imaging mass spectrometry41
A biaryl-linked tripeptide from Planomonospora reveals a widespread class of minimal RiPP gene clusters41
Probing the binding of interleukin-23 to individual receptor components and the IL-23 heteromeric receptor complex in living cells using NanoBRET41
Targeting RNA with synthetic oligonucleotides: Clinical success invites new challenges40
Pharmacological management of disease by overcoming structural adversity39
A small-molecule inhibitor of the BRCA2-RAD51 interaction modulates RAD51 assembly and potentiates DNA damage-induced cell death39
PROTAC-mediated degradation of HIV-1 Nef efficiently restores cell-surface CD4 and MHC-I expression and blocks HIV-1 replication39
The art of designed coiled-coils for the regulation of mammalian cells39
A double whammy for KEAP138
Metabolic tug-of-war: Microbial metabolism shapes colonization resistance against enteric pathogens38
An antitubercular prodrug leaves Mycobacterium tuberculosis facing a difficult choice, poisoning or starvation?38
Meet the authors: Aayushi Uberoi and Elizabeth A. Grice37
A structure-specific small molecule inhibits a miRNA-200 family member precursor and reverses a type 2 diabetes phenotype37
Splicing modulators elicit global translational repression by condensate-prone proteins translated from introns37
Emerging biochemical, microbial and immunological evidence in the search for why HLA-B∗27 confers risk for spondyloarthritis37
Mitigating the risk of antimalarial resistance via covalent dual-subunit inhibition of the Plasmodium proteasome37
SynPull: An advanced method for studying neurodegeneration-related aggregates in synaptosomes using super-resolution microscopy36
Enabling inclusion and looking ahead35
Arabinose- and xylose-modified analogs of 2′,3′-cGAMP act as STING agonists35
Small molecules targeting selective PCK1 and PGC-1α lysine acetylation cause anti-diabetic action through increased lactate oxidation35
Behavioral control through the direct, focal silencing of neuronal activity34
Humanized zebrafish as a tractable tool for in vivo evaluation of pro-myelinating drugs34
Bifunctional modalities for repurposing protein function34
A new chink in cancer’s armor: Unleashing cell death by selective PP5 inhibition34
Bioreporters for direct mode of action-informed screening of antibiotic producer strains33
Natural products chlorotonils exert a complex antibacterial mechanism and address multiple targets33
A synthetic diterpene analogue inhibits mycobacterial persistence and biofilm formation by targeting (p)ppGpp synthetases32
A potent and selective PARP14 inhibitor decreases protumor macrophage gene expression and elicits inflammatory responses in tumor explants32
Chemo-proteomics exploration of HDAC degradability by small molecule degraders31
N-Thio-β-lactams targeting L,D-transpeptidase-2, with activity against drug-resistant strains of Mycobacterium tuberculosis31
Shipworm symbiosis ecology-guided discovery of an antibiotic that kills colistin-resistant Acinetobacter30
HDAC3 and HDAC8 PROTAC dual degrader reveals roles of histone acetylation in gene regulation30
Screening in serum-derived medium reveals differential response to compounds targeting metabolism29
Cell-free production of personalized therapeutic phages targeting multidrug-resistant bacteria29
Boosting glycolysis to combat fragile bone in type 1 diabetes29
Protein acylation by saturated very long chain fatty acids and endocytosis are involved in necroptosis29
Identification of differential biological activity and synergy between the PARP inhibitor rucaparib and its major metabolite28
No acetyl-CoA keeps Plasmodium at bay28
Therapeutic induction of ferroptosis in tumors using PD-L1 targeting antibody nanogel conjugates28
Targeting ribosomal G-quadruplexes with naphthalene-diimides as RNA polymerase I inhibitors for colorectal cancer treatment28
Induced proximity in biology and therapeutics27
Characterization of an allosteric inhibitor of fungal-specific C-24 sterol methyltransferase to treat Candida albicans infections27
Phenotypic screen identifies calcineurin-sparing FK506 analogs as BMP potentiators for treatment of acute kidney injury27
Capsaicin ameliorates inflammation in a TRPV1-independent mechanism by inhibiting PKM2-LDHA-mediated Warburg effect in sepsis26
Structural basis of CD97 activation and G-protein coupling26
In vivo bioluminescence imaging of labile iron in xenograft models and liver using FeAL-1, an iron-activatable form of D-luciferin26
D-aring to explore: New approaches to gasdermin D targeting26
S-Nitrosylation-mediated dysfunction of TCA cycle enzymes in synucleinopathy studied in postmortem human brains and hiPSC-derived neurons26
PCNA degradation exhibits superior pharmacological effects over stoichiometric inhibition26
Mapping the residue specificities of epigenome enzymes by yeast surface display26
Feel the breeze: Opening the therapeutic window with RIPTACs and induced proximity26
Insights into lysophosphatidylserine recognition and Gα12/13-coupling specificity of P2Y1026
Selective killing of the human gastric pathogen Helicobacter pylori by mitochondrial respiratory complex I inhibitors26
Multiple unbiased approaches identify oxidosqualene cyclase as the molecular target of a promising anti-leishmanial26
Mo’ m1A, mo’ problems26
Repurposing of glycine transport inhibitors for the treatment of erythropoietic protoporphyria25
Fragment-linking peptide design yields a high-affinity ligand for microtubule-based transport25
Redox proteomics combined with proximity labeling enables monitoring of localized cysteine oxidation in cells25
Protomer selectivity of type II RAF inhibitors within the RAS/RAF complex25
Plant synthetic genomics: Big lessons from the little yeast25
Mechanism-based inhibition of gut microbial tryptophanases reduces serum indoxyl sulfate25
Mechanisms and functions of lysosomal lipid homeostasis24
Multiple PDE3A modulators act as molecular glues promoting PDE3A-SLFN12 interaction and induce SLFN12 dephosphorylation and cell death24
RNATACs: Multispecific small molecules targeting RNA by induced proximity24
Small molecule targeting of transcription-replication conflict for selective chemotherapy24
Identification and selectivity profiling of small-molecule degraders via multi-omics approaches24
Cannabidiol acts as molecular switch in innate immune cells to promote the biosynthesis of inflammation-resolving lipid mediators24
CDK2 heterobifunctional degraders co-degrade CDK2 and cyclin E resulting in efficacy in CCNE1-amplified and overexpressed cancers24
Targeting allostery in the Dynein motor domain with small molecule inhibitors23
Bioorthogonal dissection of the replicase assembly of hepatitis C virus23
How to kill an ERKsome target: PROTACs deliver the deathblow23
Screening compound libraries for H2O2-mediated cancer therapeutics using a peroxiredoxin-based sensor23
Discovery and biosynthesis of non-canonical C16-terpenoids from Pseudomonas23
HER2-targeted antibody-drug conjugate induces host immunity against cancer stem cells23
Discovery of a PROTAC degrader for METTL3-METTL14 complex23
Restoring two tumor suppressor pathways with one PAWI23
Epigenetic fluidity meets phenotypic malleability in intestinal epithelial cells22
A highly selective, cell-permeable furin inhibitor BOS-318 rescues key features of cystic fibrosis airway disease22
The physiological and pathological roles of RNA modifications in T cells22
Identifying and antagonizing the interactions between layilin and glycosylated collagens22
Transient hydroxycholesterol treatment restrains TCR signaling to promote long-term immunity22
Chemoproteomic profiling of substrate specificity in gut microbiota-associated bile salt hydrolases22
Integrating inflammatory biomarker analysis and artificial-intelligence-enabled image-based profiling to identify drug targets for intestinal fibrosis22
Structure-kinetic relationship reveals the mechanism of selectivity of FAK inhibitors over PYK221
CRAGE-CRISPR facilitates rapid activation of secondary metabolite biosynthetic gene clusters in bacteria21
An N terminomics toolbox combining 2-pyridinecarboxaldehyde probes and click chemistry for profiling protease specificity21
Advances and opportunities in targeted protein degradation21
Combined morphological and proteome profiling reveals target-independent impairment of cholesterol homeostasis20
Break Away: FKBP12 sequestration as a target for increasing BMP activity20
Excited to see you: New imaging approaches to detect ferrous iron in vivo20
Discovery of YAP1/TAZ pathway inhibitors through phenotypic screening with potent anti-tumor activity via blockade of Rho-GTPase signaling20
Targeting VPS41 induces methuosis and inhibits autophagy in cancer cells20
Chemically modified guide RNAs enhance CRISPR-Cas13 knockdown in human cells19
Synergistic PIM kinase and proteasome inhibition as a therapeutic strategy for MYC-overexpressing triple-negative breast cancer19
Targeting selective E3 ligase for healing cardiac fibrosis19
The chemistry of electrical signaling in sodium channels from bacteria and beyond19
Inhibitors of the ATPase p97/VCP: From basic research to clinical applications19
Accelerating multiplexed profiling of protein-ligand interactions: High-throughput plate-based reactive cysteine profiling with minimal input19
Tools to investigate the cell surface: Proximity as a central concept in glycoRNA biology19
CLK2 and CLK4 are regulators of DNA damage-induced NF-κB targeted by novel small molecule inhibitors19
Identification of small molecules that strongly inhibit bacterial quorum sensing using a high-throughput lipid vesicle lysis assay19
PARP trapping is governed by the PARP inhibitor dissociation rate constant19
Biogenesis and roles of tRNA queuosine modification and its glycosylated derivatives in human health and diseases19
Anti-tumor immunotherapy using engineered bacterial outer membrane vesicles fused to lysosome-targeting chimeras mediated by transferrin receptor19
Voices: Challenges and opportunities for bioorthogonal chemistry19
Targeting N-Myc in neuroblastoma with selective Aurora kinase A degraders19
Quinoline-based compounds can inhibit diverse enzymes that act on DNA18
Inhibiting GLUTtony in cancer18
Discovery of a mu-opioid receptor modulator that in combination with morphinan antagonists induces analgesia18
The dark side of circular RNA, a new driver of genome instability18
The liquid lectin array detects compositional glycocalyx differences using multivalent DNA-encoded lectins on phage18
How do you mend inactive tumor suppressor mutants? You glue them!18
Targeted epigenetic induction of mitochondrial biogenesis enhances antitumor immunity in mouse model18
Addressing the Enzyme-independent tumor-promoting function of NAMPT via PROTAC-mediated degradation18
Bortezomib inhibits ZIKV/DENV by interfering with viral polyprotein cleavage via the ERAD pathway17
MICU1 controls the sensitivity of the mitochondrial Ca2+ uniporter to activators and inhibitors17
Small-molecule allosteric inhibitors of GPX417
Ligand discovery by activity-based protein profiling17
Phosphorylation barcodes direct biased chemokine signaling at CXCR317
Temsavir blocks the immunomodulatory activities of HIV-1 soluble gp12017
Facile generation of biepitopic antibodies with intrinsic agonism for activating tumor necrosis factor receptors17
Irreversible inhibition of TRF2TRFH recruiting functions by a covalent cyclic peptide induces telomeric replication stress in cancer cells17
Naturally occurring three-way junctions can be repurposed as genetically encoded RNA-based sensors17
Monitoring autophagic flux in vivo revealed its physiological response and significance of heterogeneity in pancreatic beta cells17
One-pot trimodal mapping of unmethylated, hydroxymethylated, and open chromatin sites unveils distinctive 5hmC roles at dynamic chromatin loci17
A sterol analog inhibits hedgehog pathway by blocking cholesterylation of smoothened16
In vivo bioluminescence imaging of granzyme B activity in tumor response to cancer immunotherapy16
Strategies of bacterial detection by inflammasomes16
Cellular reprogramming by protein degradation: The next frontier in cancer immunotherapy16
Exploiting polypharmacology to dissect host kinases and kinase inhibitors that modulate endothelial barrier integrity16
Meet the authors: Cydney N. Johnson, Shyra Wilde, Elaine Tuomanen, and Jason W. Rosch16
Temporal resolution of gene derepression and proteome changes upon PROTAC-mediated degradation of BCL11A protein in erythroid cells16
Visualization of the dynamic interaction between nucleosomal histone H3K9 tri-methylation and HP1α chromodomain in living cells16
Plug and play with recombinant antibody fragments16
NUDT15-mediated hydrolysis limits the efficacy of anti-HCMV drug ganciclovir16
Targeted degradation of CDK9 potently disrupts the MYC-regulated network16
Identification of Pax protein inhibitors that suppress target gene expression and cancer cell proliferation16
Clionamines stimulate autophagy, inhibit Mycobacterium tuberculosis survival in macrophages, and target Pik116
A “light” touch on PI3K to interrogate cancer drug resistance16
The culinary chemist: Out of the lab and into the tent16
METTL3: Melting the tumor microenvironment for improved immunotherapy16
0.051657915115356